Skip to main content

72 Investment Holdings, LLC

13F filer · CIK 0001832749
Reported Aug 14, 2026
13F portfolio value$50MU.S. long equity reported on 13F
Positions50 new · 0 closed
Net flow last quarter$0Buys minus sells
Top 10 positions weight100.0%Concentration

Holdings

13F · last 4 quarters free
Scroll for earlier quarters
CompanyValue% of portfolio% of companyPOSITION CHANGE qoq %First reported
Q2 2026Reported Aug 14, 20265 positions
PRAXPraxis Precision Medicines, Inc.$22.1M44.18%0.24%Not reportedQ4 2020
ANROAlto Neuroscience, Inc.$17.6M35.27%1.90%Not reportedQ1 2024
LENZLENZ Therapeutics, Inc.$5.78M11.57%3.24%Not reportedQ1 2024
KRROKorro Bio, Inc.$3.65M7.30%1.88%Not reportedQ4 2023
CRBUCaribou Biosciences, Inc.$834K1.67%0.45%Not reportedQ3 2021
Q1 2026Reported May 15, 20265 positions
PRAXPraxis Precision Medicines, Inc.$21.2M42.83%0.24%Not reportedQ4 2020
ANROAlto Neuroscience, Inc.$15M30.26%1.91%Not reportedQ1 2024
LENZLENZ Therapeutics, Inc.$9.31M18.77%3.25%Not reportedQ1 2024
KRROKorro Bio, Inc.$3.13M6.32%1.92%Not reportedQ4 2023
CRBUCaribou Biosciences, Inc.$901K1.82%0.49%Not reportedQ3 2021
Q4 2025Reported Feb 17, 20265 positions
PRAXPraxis Precision Medicines, Inc.$19.4M38.42%0.26%Not reportedQ4 2020
LENZLENZ Therapeutics, Inc.$16.3M32.20%3.25%Not reportedQ1 2024
ANROAlto Neuroscience, Inc.$11.9M23.50%2.09%Not reportedQ1 2024
KRROKorro Bio, Inc.$2.22M4.38%2.94%Not reportedQ4 2023
CRBUCaribou Biosciences, Inc.$754K1.49%0.50%Not reportedQ3 2021
Q3 2025Reported Nov 14, 20255 positions
LENZLENZ Therapeutics, Inc.$47.4M69.77%3.56%Not reportedQ1 2024
KRROKorro Bio, Inc.$13.3M19.51%2.95%Not reportedQ4 2023
PRAXPraxis Precision Medicines, Inc.$3.49M5.14%0.31%Not reportedQ4 2020
ANROAlto Neuroscience, Inc.$2.68M3.95%2.46%Not reportedQ1 2024
CRBUCaribou Biosciences, Inc.$1.1M1.63%0.51%Not reportedQ3 2021
Premium opens every quarter this fund has filed

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.